These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 618241)

  • 21. Levosimendan is not effective in reducing pulmonary pressures in patients with idiopathic pulmonary arterial hypertension: report of two cases.
    Cavusoglu Y; Beyaztas A; Birdane A; Ata N
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):503-7. PubMed ID: 19346968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repetitive dosing of intravenous levosimendan improves pulmonary hemodynamics in patients with pulmonary hypertension: results of a pilot study.
    Kleber FX; Bollmann T; Borst MM; Costard-Jäckle A; Ewert R; Kivikko M; Petterson T; Pohjanjousi P; Sonntag S; Wikström G
    J Clin Pharmacol; 2009 Jan; 49(1):109-15. PubMed ID: 18981240
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prazosin, a new peripheral vasodilator agent compared with hydralazine].
    Rasmussen K; Aerenlund Jensen H
    Ugeskr Laeger; 1976 Aug; 138(32):1940-3. PubMed ID: 951801
    [No Abstract]   [Full Text] [Related]  

  • 24. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dihydrazaline (Depressan) treatment of eclampsia imminens and eclampsia].
    Seifert B; Woraschk HJ
    Zentralbl Gynakol; 1974 Apr; 96(7):540-4. PubMed ID: 4844082
    [No Abstract]   [Full Text] [Related]  

  • 26. [Diclofurime, a new major hypotensive agent. Clinical study in 24 patients (author's transl)].
    Letac B; Chevallier B; Cribier A; Barthes P
    Nouv Presse Med; 1980 Mar; 9(10):701-4. PubMed ID: 7375348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BQ 22-708, a new antihypertensive agent with vasodilator properties.
    Oates HF
    N Z Med J; 1980 Mar; 91(655):192. PubMed ID: 6929992
    [No Abstract]   [Full Text] [Related]  

  • 28. [The pharmacodynamic and hypotensive efficacy of proxodolol in an acute drug test on hypertension patients].
    Kukes VG; Starodubtsev AK; Smirnov MV; Petrov IN
    Eksp Klin Farmakol; 1994; 57(3):45-7. PubMed ID: 7914120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemodynamic changes and left ventricular function in patients with hypertension during an acute trial of urapidil].
    Sirakova V; Penkov N; Penev A
    Vutr Boles; 1988; 27(5):20-3. PubMed ID: 3062899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring an optimum intra/postoperative management strategy for acute hypertension in the cardiac surgery patient.
    Cheung AT
    J Card Surg; 2006; 21 Suppl 1():S8-S14. PubMed ID: 16492294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Behavior of arterial pressure, hemodynamic parameters, sympathetic nervous system activity and plasma volume during treatment with a vasodilating and beta-blocking drug in essential hypertension patients].
    Fariello R; Alicandri C; Agabiti-Rosei E; Romanelli G; Montini E; Muiesan ML; Minniti P; Castellano M; Beschi M; Boni E; Zaninelli A; Micheli P; Platto L; Leto Di Priolo S; Muiesan G
    Boll Soc Ital Cardiol; 1981; 26(11):1871-4. PubMed ID: 6129877
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the antihypertensive activity of cadralazine (ISF 2469) and dihydralazine during chronic treatment.
    Strocchi E; Costa FV; Caldari R; Malini PL; Marata AM; Parini J; Ambrosioni E
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):519-23. PubMed ID: 6642790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [When hypertension becomes an emergency case: lower the blood pressure, but slowly!].
    Stiefelhagen P
    MMW Fortschr Med; 2003 May; 145(22):10. PubMed ID: 12866264
    [No Abstract]   [Full Text] [Related]  

  • 34. Clevidipine (Cleviprex) for IV treatment of severe hypertension.
    Med Lett Drugs Ther; 2008 Sep; 50(1295):73-4. PubMed ID: 18800023
    [No Abstract]   [Full Text] [Related]  

  • 35. Antihypertensive activity of a new vasodilator, cadralazine, administered alone or in combination with a beta-blocker.
    Buoninconti R; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):613-6. PubMed ID: 2867048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antihypertensive pharmacotherapy with the vasodilators captopril and endralazine].
    Hartmann HG; Schumacher H
    Schweiz Med Wochenschr; 1985 Jul; 115(27-28):939-44. PubMed ID: 2862703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current problems in hypotensive treatment].
    Sznajderman M
    Wiad Lek; 1983 Mar; 36(5):413-24. PubMed ID: 6135281
    [No Abstract]   [Full Text] [Related]  

  • 38. [Open pilot study of the activity and tolerability of cadralazine in hypertensive patients resistant to other therapy].
    Angelino PF; Bensoni M; Gastaldo D; Minelli M; Parini M; Lavezzaro GC
    Minerva Cardioangiol; 1982 Mar; 30(3):69-74. PubMed ID: 7088296
    [No Abstract]   [Full Text] [Related]  

  • 39. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drugs for hypertensive emergencies.
    Med Lett Drugs Ther; 1989 Apr; 31(789):32-4. PubMed ID: 2927362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.